News

Cathy Tie slips on a white lab coat bearing her name and the logo of her startup: Origin Genomics. "Welcome!" she says as she leads an NPR reporter, photographer and videographer on an exclusive tour of Origin's labs located...

This is the 17th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. The series is organized by Osagie K. Obasogie in...

THE INSTAGRAM POST, precision-guided by sex and age, had zeroed in on its target. Yuchen Tu is a conser­vatory-trained viola...

This is the 16th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring...

Genesis Egg Donation & Surrogacy Group, Pasadena, CA.
By Kevin Smith, San Gabriel Valley Tribune | 04.30.2016
Untitled Document

With China’s controversial one-child policy no longer in effect, the U.S. is seeing a huge jump in surrogacy-related...

By Jessica Hamzelou, New Scientist | 04.29.2016
Untitled Document

Who stands to benefit from – or lose out on – gene editing? Advances in our ability to...

By Alex Lash, Xconomy | 04.29.2016
Untitled Document

Boston — An icy March wind was blowing across the Charles River, but in the laboratory of Intellia...

By Sarah Zhang, WIRED | 04.28.2016
Untitled Document

The breast cancer genes BRCA1 and BRCA2 ar two of the famous sequences of DNA in the world...

By Ed Yong, The Atlantic | 04.28.2016
Untitled Document

Aboard the International Space Station, six people are currently orbiting the planet at 17,000 miles per hour, taking...

By Editorial Board, The Chicago Tribune | 04.27.2016
Untitled Document

On Friday, scientists and policymakers meet in a Paris summit to grapple over the ethics and science of...

Francis deSouza joined Illumina in 2013 as president.
By Christine Farr, Fast Company | 04.27.2016
Untitled Document

A simple blood test to detect early signs of cancer. A noninvasive way to screen pregnancies for common...

By Sharon Begley, STAT | 04.27.2016
Untitled Document

Molecule by molecule, the transformational genome-editing technology called CRISPR-Cas9 is getting so many upgrades so quickly it’s like...